Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases

Sergio Recalde, Agustin Tortajada, Marta Subias, Jaouad Anter, Miquel Blasco, Ramona Maranta, Rosa Coco, Sheila Pinto, Marina Noris, Alfredo García-Layana, Santiago Rodríguez De Córdoba

Research output: Contribution to journalArticle

Abstract

The complement factor H (FH) mutation R1210C, which was described in association with atypical hemolytic uremic syndrome (aHUS), also confers high risk of age-related macular degeneration (AMD) and associates with C3 glomerulopathy (C3G). To reveal the molecular basis of these associations and to provide insight into what determines the disease phenotype in FH-R1210C carriers, we identified FH-R1210C carriers in our aHUS, C3G, and AMD cohorts. Disease status, determined in patients and relatives, revealed an absence of AMD phenotypes in the aHUS cohort and, vice versa, a lack of renal disease in the AMD cohort. These findings were consistent with differences in the R1210C-independent overall risk for aHUS and AMD between mutation carriers developing one pathology or the other. R1210C is an unusual mutation that generates covalent complexes between FH and HSA. Using purified FH proteins and surface plasmon resonance analyses, we demonstrated that formation of these FH-HSA complexes impairs accessibility to all FH functional domains. These data suggest that R1210C is a unique C-terminal FH mutation that behaves as a partial FH deficiency, predisposing individuals to diverse pathologies with distinct underlying pathogenic mechanisms; the final disease outcome is then determined by R1210C-independent genetic risk factors.

Original languageEnglish
Pages (from-to)1305-1311
JournalJournal of the American Society of Nephrology : JASN
Volume27
Issue number5
DOIs
Publication statusPublished - 2016

Fingerprint

Complement Factor H
Eye Diseases
Macular Degeneration
Kidney
Mutation
Pathology
Phenotype
Surface Plasmon Resonance
Atypical Hemolytic Uremic Syndrome

Keywords

  • Journal Article

Cite this

Recalde, S., Tortajada, A., Subias, M., Anter, J., Blasco, M., Maranta, R., ... Rodríguez De Córdoba, S. (2016). Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases. Journal of the American Society of Nephrology : JASN, 27(5), 1305-1311. https://doi.org/10.1681/ASN.2015050580

Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases. / Recalde, Sergio; Tortajada, Agustin; Subias, Marta; Anter, Jaouad; Blasco, Miquel; Maranta, Ramona; Coco, Rosa; Pinto, Sheila; Noris, Marina; García-Layana, Alfredo; Rodríguez De Córdoba, Santiago.

In: Journal of the American Society of Nephrology : JASN, Vol. 27, No. 5, 2016, p. 1305-1311.

Research output: Contribution to journalArticle

Recalde, S, Tortajada, A, Subias, M, Anter, J, Blasco, M, Maranta, R, Coco, R, Pinto, S, Noris, M, García-Layana, A & Rodríguez De Córdoba, S 2016, 'Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases', Journal of the American Society of Nephrology : JASN, vol. 27, no. 5, pp. 1305-1311. https://doi.org/10.1681/ASN.2015050580
Recalde, Sergio ; Tortajada, Agustin ; Subias, Marta ; Anter, Jaouad ; Blasco, Miquel ; Maranta, Ramona ; Coco, Rosa ; Pinto, Sheila ; Noris, Marina ; García-Layana, Alfredo ; Rodríguez De Córdoba, Santiago. / Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases. In: Journal of the American Society of Nephrology : JASN. 2016 ; Vol. 27, No. 5. pp. 1305-1311.
@article{9ba837cf3dee46a38d68f7188ce1b41b,
title = "Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases",
abstract = "The complement factor H (FH) mutation R1210C, which was described in association with atypical hemolytic uremic syndrome (aHUS), also confers high risk of age-related macular degeneration (AMD) and associates with C3 glomerulopathy (C3G). To reveal the molecular basis of these associations and to provide insight into what determines the disease phenotype in FH-R1210C carriers, we identified FH-R1210C carriers in our aHUS, C3G, and AMD cohorts. Disease status, determined in patients and relatives, revealed an absence of AMD phenotypes in the aHUS cohort and, vice versa, a lack of renal disease in the AMD cohort. These findings were consistent with differences in the R1210C-independent overall risk for aHUS and AMD between mutation carriers developing one pathology or the other. R1210C is an unusual mutation that generates covalent complexes between FH and HSA. Using purified FH proteins and surface plasmon resonance analyses, we demonstrated that formation of these FH-HSA complexes impairs accessibility to all FH functional domains. These data suggest that R1210C is a unique C-terminal FH mutation that behaves as a partial FH deficiency, predisposing individuals to diverse pathologies with distinct underlying pathogenic mechanisms; the final disease outcome is then determined by R1210C-independent genetic risk factors.",
keywords = "Journal Article",
author = "Sergio Recalde and Agustin Tortajada and Marta Subias and Jaouad Anter and Miquel Blasco and Ramona Maranta and Rosa Coco and Sheila Pinto and Marina Noris and Alfredo Garc{\'i}a-Layana and {Rodr{\'i}guez De C{\'o}rdoba}, Santiago",
note = "Copyright {\circledC} 2016 by the American Society of Nephrology.",
year = "2016",
doi = "10.1681/ASN.2015050580",
language = "English",
volume = "27",
pages = "1305--1311",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "5",

}

TY - JOUR

T1 - Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases

AU - Recalde, Sergio

AU - Tortajada, Agustin

AU - Subias, Marta

AU - Anter, Jaouad

AU - Blasco, Miquel

AU - Maranta, Ramona

AU - Coco, Rosa

AU - Pinto, Sheila

AU - Noris, Marina

AU - García-Layana, Alfredo

AU - Rodríguez De Córdoba, Santiago

N1 - Copyright © 2016 by the American Society of Nephrology.

PY - 2016

Y1 - 2016

N2 - The complement factor H (FH) mutation R1210C, which was described in association with atypical hemolytic uremic syndrome (aHUS), also confers high risk of age-related macular degeneration (AMD) and associates with C3 glomerulopathy (C3G). To reveal the molecular basis of these associations and to provide insight into what determines the disease phenotype in FH-R1210C carriers, we identified FH-R1210C carriers in our aHUS, C3G, and AMD cohorts. Disease status, determined in patients and relatives, revealed an absence of AMD phenotypes in the aHUS cohort and, vice versa, a lack of renal disease in the AMD cohort. These findings were consistent with differences in the R1210C-independent overall risk for aHUS and AMD between mutation carriers developing one pathology or the other. R1210C is an unusual mutation that generates covalent complexes between FH and HSA. Using purified FH proteins and surface plasmon resonance analyses, we demonstrated that formation of these FH-HSA complexes impairs accessibility to all FH functional domains. These data suggest that R1210C is a unique C-terminal FH mutation that behaves as a partial FH deficiency, predisposing individuals to diverse pathologies with distinct underlying pathogenic mechanisms; the final disease outcome is then determined by R1210C-independent genetic risk factors.

AB - The complement factor H (FH) mutation R1210C, which was described in association with atypical hemolytic uremic syndrome (aHUS), also confers high risk of age-related macular degeneration (AMD) and associates with C3 glomerulopathy (C3G). To reveal the molecular basis of these associations and to provide insight into what determines the disease phenotype in FH-R1210C carriers, we identified FH-R1210C carriers in our aHUS, C3G, and AMD cohorts. Disease status, determined in patients and relatives, revealed an absence of AMD phenotypes in the aHUS cohort and, vice versa, a lack of renal disease in the AMD cohort. These findings were consistent with differences in the R1210C-independent overall risk for aHUS and AMD between mutation carriers developing one pathology or the other. R1210C is an unusual mutation that generates covalent complexes between FH and HSA. Using purified FH proteins and surface plasmon resonance analyses, we demonstrated that formation of these FH-HSA complexes impairs accessibility to all FH functional domains. These data suggest that R1210C is a unique C-terminal FH mutation that behaves as a partial FH deficiency, predisposing individuals to diverse pathologies with distinct underlying pathogenic mechanisms; the final disease outcome is then determined by R1210C-independent genetic risk factors.

KW - Journal Article

U2 - 10.1681/ASN.2015050580

DO - 10.1681/ASN.2015050580

M3 - Article

C2 - 26376859

VL - 27

SP - 1305

EP - 1311

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 5

ER -